Adherium Limited (ADR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -11.98 Million AUD | -1.52% |
| 2023 | -11.91 Million AUD | 7.23% |
| 2022 | -12.84 Million AUD | -3.84% |
| 2021 | -12.36 Million AUD | -38.59% |
| 2020 | -8.92 Million AUD | 23.02% |
| 2019 | -11.59 Million AUD | -20.25% |
| 2018 | -9.63 Million AUD | 31.65% |
| 2017 | -14.1 Million AUD | -110.96% |
| 2016 | -6.68 Million AUD | -469.4% |
| 2015 | -1.17 Million AUD | 48.61% |
| 2014 | -2.28 Million AUD | -1544.5% |
| 2013 | -138.9 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -11.98 Million AUD | -0.62% |
| 2024 Q4 | -6.68 Million AUD | 0.0% |
| 2024 Q2 | -5.3 Million AUD | 0.0% |
| 2023 FY | -11.91 Million AUD | 7.23% |
| 2023 Q4 | -5.46 Million AUD | 0.0% |
| 2023 Q2 | -6.43 Million AUD | 0.0% |
| 2022 Q4 | -6.64 Million AUD | 0.0% |
| 2022 FY | -12.84 Million AUD | -3.84% |
| 2022 Q2 | -6.19 Million AUD | 0.0% |
| 2021 Q2 | -7.16 Million AUD | 0.0% |
| 2021 Q4 | -4.83 Million AUD | 0.0% |
| 2021 FY | -12.36 Million AUD | -38.59% |
| 2020 Q2 | -3.53 Million AUD | 0.0% |
| 2020 Q4 | -5.27 Million AUD | 0.0% |
| 2020 FY | -8.92 Million AUD | 23.02% |
| 2019 FY | -11.59 Million AUD | -20.25% |
| 2019 Q4 | -3.21 Million AUD | 0.0% |
| 2019 Q2 | -8.71 Million AUD | 0.0% |
| 2018 Q4 | -4.49 Million AUD | 0.0% |
| 2018 Q2 | -5.14 Million AUD | 0.0% |
| 2018 FY | -9.63 Million AUD | 31.65% |
| 2017 Q2 | -5.17 Million AUD | 0.0% |
| 2017 FY | -14.1 Million AUD | -110.96% |
| 2017 Q4 | -8.25 Million AUD | 0.0% |
| 2016 FY | -6.68 Million AUD | -469.4% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | -1.17 Million AUD | 48.61% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | -2.28 Million AUD | -1544.5% |
| 2013 FY | -138.9 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 57.144% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -22.453% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -174.799% |
| Anteris Technologies Ltd | -66.63 Million AUD | 82.013% |
| Control Bionics Limited | -5.92 Million AUD | -102.138% |
| CardieX Limited | -4.63 Million AUD | -158.655% |
| Compumedics Limited | -269 Thousand AUD | -4355.506% |
| Cochlear Limited | 521.5 Million AUD | 102.298% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -148.97% |
| Cyclopharm Limited | -9.22 Million AUD | -29.927% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -642.396% |
| Nova Eye Medical Limited | -3.79 Million AUD | -215.652% |
| HeraMED Limited | -6.42 Million AUD | -86.455% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 31.806% |
| ImpediMed Limited | -19.03 Million AUD | 37.039% |
| InhaleRx Limited | -1.38 Million AUD | -764.437% |
| LBT Innovations Limited | -4.74 Million AUD | -152.855% |
| Micro-X Limited | -13.02 Million AUD | 7.996% |
| Neurotech International Limited | -5.58 Million AUD | -114.606% |
| OncoSil Medical Limited | -11.98 Million AUD | -0.009% |
| PolyNovo Limited | 1.16 Million AUD | 1130.551% |
| Respiri Limited | -7 Million AUD | -71.214% |
| SomnoMed Limited | -3.84 Million AUD | -212.012% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 28.147% |
| Uscom Limited | -2.4 Million AUD | -398.485% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -104.733% |